Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postpartum haemorrhage.

C McLintock1

  • 1Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand.

Thrombosis Research
|March 26, 2005
PubMed
Summary
This summary is machine-generated.

Postpartum hemorrhage (PPH) is a major cause of maternal death globally. Prompt recognition and management, including blood product replacement and potential use of recombinant Factor VIIa, are crucial for improving outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high-income setting: a prospective cohort study.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Women with bleeding disorders: Clinical and psychological issues.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

[Peripheral ulcerative keratitis refractory to therapy in a young female patient].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same author

Maternal and fetal outcomes of primary immune thrombocytopenia during pregnancy: A retrospective study.

Obstetric medicine·2018
Same author

Anticoagulant options in pregnancy for women with mechanical valves.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.

BMC pregnancy and childbirth·2016
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Maternal Health
  • Hemorrhage Management

Background:

  • Postpartum hemorrhage (PPH) is a leading cause of maternal mortality, particularly in developing nations.
  • Pregnancy-induced physiological changes can accelerate severe hemorrhage and disseminated intravascular coagulation (DIC).
  • While antenatal risk assessment identifies some high-risk pregnancies, intrapartum complications frequently precipitate severe PPH.

Discussion:

  • Effective management of severe PPH requires prompt recognition and intervention.
  • Key management strategies include surgical correction of bleeding, plasma component replacement to address coagulopathy, and red blood cell transfusion for tissue oxygenation.
  • Recombinant Factor VIIa presents a potential adjunct for life-threatening obstetric hemorrhage, but requires further clinical validation.

Related Experiment Videos

Key Insights:

  • Vigilance for PPH is essential, considering physiological adaptations during pregnancy.
  • A combination of surgical and supportive medical management is critical for PPH control.
  • The role of recombinant Factor VIIa in massive obstetric hemorrhage warrants further investigation.

Outlook:

  • Continued research into PPH management strategies is vital.
  • Further clinical trials are needed to establish the safety and efficacy of novel hemostatic agents like recombinant Factor VIIa.
  • Improving global maternal health outcomes necessitates enhanced PPH recognition and treatment protocols.